Trend of "2+10" E-cigarettes in the UK, No Large-screen Design

Market by 2FIRSTS
Dec.12.2024
Trend of "2+10" E-cigarettes in the UK, No Large-screen Design
New "2+10" e-cigarette products from Aladdin, VOOPOO, and Pantherbar hit the UK market ahead of 2024.

Special notice:

1. This article is for internal industry communication purposes only and does not make any endorsements of brands or products.

2. The images presented in this article are used solely for factual description and are not intended as advertisements for any products.

3. Minors are prohibited from accessing this article.


As the end of 2024 approaches, a new batch of "2+10" e-cigarettes has emerged in the UK market, involving e-cigarette brands such as Aladdin, VOOPOO, and pantherbar. 2Firsts has gathered and analyzed the new "2+10" e-cigarette products launched on the websites of e-cigarette distributors in the UK, aiming to examine the trend of this type of e-cigarette products.

 

Aladdin Pro Enjoy X 10000

 

The e-cigarette Aladdin Pro Enjoy X 10000 is launched by the brand Aladdin PRO, which originates from Malaysia and was founded in 2019. Its product line includes disposable e-cigarettes, open systems, e-liquids, and more.

 

Trend of
Aladdin Pro Enjoy X 10000 | Image Source: vapesourcing

 

Specifically, the product features of Aladdin Pro Enjoy X 10000 include:

 

Trend of
Aladdin Pro Enjoy X 10000 Parameter Information | Illustration: 2Firsts

 

Currently, the Aladdin Pro Enjoy X 10000 has been launched on the e-cigarette distributor website vapesourcing targeting the UK market, with a selling price of around £10.99. As of the time of writing, this product has not yet been listed on the official website of the Aladdin PRO brand.

 

Trend of
Aladdin PRO Introduction | Image Source: Aladdin PRO Official Website

 

Dripped Fusion 6000

 

The e-cigarette Dripped Fusion 6000 is launched by Pantherbar. Specifically, the product features of Dripped Fusion 6000 include:

 

Trend of
Dripped Fusion 6000 parameter information | Graphics: 2Firsts

 

Currently, Dripped Fusion 6000 has been launched on multiple UK e-cigarette retailers' websites such as vapeuk and vapesourcing, with a selling price of around 11.99 pounds.

 

Trend of
Pantherbar releases advertising information for Dripped Fusion 6000 | Image source: ins

 

Specifically, the features of the VOOPOO Argus Bar Pro Max 6000 include:

 

Trend of
VOOPOO Argus Bar Pro Max 6000|Image source: vapeclub

 

VOOPOO Argus Bar Pro Max 6000

 

The VOOPOO Argus Bar Pro Max 6000 is a new e-cigarette model released by the well-known e-cigarette brand VOOPOO. Previously, the brand also introduced its first disposable water pipe-style e-cigarette. 

 

Trend of
VOOPOO Argus Bar Pro Max 6000 parameter information | Design by: 2Firsts.

 

The product features a cylindrical design in terms of appearance, setting it apart from the two 2+10 products mentioned earlier. Currently, the VOOPOO Argus Bar Pro Max 6000 has been launched on several UK e-cigarette retailer websites such as vapeclub and vapesourcing, with a price tag of around £11.99.

 

Trend of
VOOPOO Argus Bar Pro Max 6000 | Image source: vapeclub

 


The 2FIRSTS section focuses on providing readers with the latest product information in the tobacco industry, and welcomes readers to submit articles and share new products in the e-cigarette field in order to collect and share firsthand industry information more widely.

 

If you have any unique insights or information, please feel free to contact us at info@2firsts.com at any time.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08